21/08/2026
“As Indian pharma companies expand globally, three export lanes create the most logistics compliance problems:
Lane 1 — India to USA: FDA import alert risk is highest here. Documentation gaps in logistics records have triggered import holds on otherwise compliant products.
Lane 2 — India to EU (Germany, Netherlands, Belgium): EU GDP compliance is the strictest globally. Carrier qualification documentation is mandatory — most Indian forwarders do not provide it.
Lane 3 — India to Africa and emerging markets: Fewer regulatory bodies, but WHO GDP requirements still apply for UNICEF and global health supply chain contracts.
Blue Wing Global operates all three lanes with full compliance documentation.
Which market are you expanding into next?
bluewingglobal.com
AfricaPharma PharmaLogistics”